Tổng Quan
- Danh pháp khoa học
- Aloysia triphylla
- Họ thực vật
- Verbenaceae
- Bộ phận dùng
- Leaves
- Phương pháp chiết xuất
- Steam distillation
- Màu sắc
- —
- Phân loại nốt hương
- Nốt Top
- Hương thơm
- —
- Chemotype / Cultivar
- —
Tình trạng tại Việt Nam
Xem chi tiết
Bright, sweet-lemon-citrus, slightly-floral-sweet, fresh, with subtle herbal-green undertone; classic "lemon verbena tea" vernacular character
Tươi sáng, ngọt-chanh-citrus, hơi ngọt-floral, trong lành, có nốt herbal-xanh nhẹ; mùi đặc trưng "trà lemon verbena" cổ điển
2–4 giờ
Tên gọi tại Việt Nam
Pha Chế & Hòa Hợp
Citral (geranial + neral 52–68%) is central to the relaxant, calming properties associated with lemon-scented aldehyde EOs; traditional cedrón herbalism for anxiety, insomnia, and nervous tension is widely documented across South American and European traditions.
Ref: Tisserand & Young 2014, Ch.13 — class-extrapolation from citral-dominant EO cluster; B216 p.882-884 traditional use commentary
Traditional Verbenaceae ethnopharmacology employs Aloysia triphylla leaf preparations for digestive spasm, colic, and dyspepsia; concentrated EO is pharmacologically distinct from leaf infusion and must be applied at controlled dilutions.
Ref: Traditional Verbenaceae ethnopharmacology (South American cedrón use); B216 p.882-884
Citral suppresses pro-inflammatory cytokines in cell-culture models; (+)-limonene as co-constituent contributes via NF-κB pathway modulation; extrapolated from the citral-class cluster, not from Aloysia-specific in-vivo studies.
Ref: class-extrapolation from may-chang/litsea (EO057) citral 70–85% + myrtle-lemon (EO776) citral 78–100%; Tisserand & Young 2014, Ch.14
Citral reduced plasma insulin and improved glucose tolerance in a 28-day rat oral-dosing study; clinical magnitude at aromatherapy dilutions is unknown; rated 2 — animal study only, not a human clinical outcome.
Ref: Modak & Mukhopadhaya 2011; Tisserand & Young 2014 Table 4.10B antidiabetic class-rail
Lemon verbena EO and isolated citral induced apoptosis in CLL blood cells ex-vivo; rated 2 — cell-culture data only, NOT a clinical oncology claim and must not be communicated as cancer treatment.
Ref: De Martino et al 2009b — lemon verbena EO + citral CLL-blood ex-vivo apoptosis study
Citral-dominant EOs exert broad antimicrobial activity against Gram-positive and Gram-negative organisms and fungi via membrane disruption; well-established for the acyclic-monoterpene-aldehyde class.
Ref: class-extrapolation from myrtle-lemon (EO776) + may-chang/litsea (EO057); Tisserand & Young 2014, Ch.13
Citral (geranial + neral 52–68%) is a well-documented mosquito and insect deterrent established across citral-dominant EOs; inhalation and very-low-concentration diffusion are the safer delivery routes given dermal cap and phototoxicity constraints.
Ref: class-extrapolation from citral-dominant insect-repellent EO cluster; Tisserand & Young 2014, Ch.13
AI-summary
No RCT-grade clinical evidence located for Lemon Verbena EO in aromatherapy. Strongest available evidence: (1) De Martino et al 2009b — ex-vivo study demonstrating lemon verbena EO and isolated citral induced apoptosis in CLL blood cells (preliminary antiproliferative signal; cell-culture only, not clinical). (2) Modak & Mukhopadhaya 2011 — 28-day rat study showing citral reduced plasma insulin and improved glucose tolerance (animal model; not human outcome). Ford et al 1992 (RIFM monograph) provides acute LD50 toxicological data and 6-sample sensitization variability, including mildly phototoxic results at undiluted concentration. Therapeutic applications (anxiolytic, antispasmodic, digestive) are based on traditional South American cedrón herbalism and Verbenaceae class consensus, not clinical trials. No RCTs available for aromatherapy dilutions.
NarrativeTâm trạng: Uplifting, Stimulating
Chakra
solar
Ngũ hành
moc
| Phương pháp | Liều lượng | Ghi chú |
|---|---|---|
| Diffusion / Aromatic inhalation | 2–4 drops in 100 ml water or 2–3 drops on tissue | Safest route; avoids dermal sensitization and phototoxicity. Inhalation does not activate CYP2B6 at typical doses. Limit to 30 min sessions. Avoid enclosed spaces with pregnant women. |
| Topical massage | 0.5–0.9% in carrier oil (T&Y hard cap: 0.9% via citral 68% × IFRA 0.6%) | Phototoxic: avoid sun/UV 12–18 hr post-use. Contraindicated in pregnancy. Patch-test essential (citral sensitization 0.5%). Avoid bupropion/efavirenz/methadone (CYP2B6 DI). Avoid damaged skin. |
| Skincare blend (evening only) | 0.3–0.5% in facial or body product | Evening/night products strictly (phototoxic). Oily or combination skin only. Not for sensitive, dry, or sensitized skin. Contraindicated in pregnancy. Check co-formulation for cumulative citral load. |
| Aromatic bath | 3–5 drops in 1 tbsp carrier oil or full-fat milk, then added to bath | Pre-dilute in emulsifier to prevent undiluted citral skin contact. Avoid UV post-bath. Contraindicated in pregnancy. Not for sensitive skin. Keep water temperature moderate. |
| Cold compress (localized) | 2–3 drops in 200 ml cool water on compress cloth | Traditional cedrón adjunct for headache or mild fever. Cover skin post-application and avoid sun on treated area. Contraindicated in pregnancy. Patch-test first. |
Dầu nền phù hợp
Kết hợp tốt với
Blend kinh điển
An Toàn
Giới hạn da tối đa
Xem chi tiết
Giới hạn IFRA
Xem chi tiết
Thai kỳ & Cho con bú
Giới hạn độ tuổi
Xem chi tiết
Bảo quản
Bảo quản nơi tối, mát